Episode 169: migraine, plantar fasciitis, beta-blocker duration and prostate cancer episode artwork

EPISODE · Dec 4, 2024 · 28 MIN

Episode 169: migraine, plantar fasciitis, beta-blocker duration and prostate cancer

from Primary Care Update · host Mark Ebell

This week Mark, Kate, Gary and Henry talk about the comparative effectiveness of migraine medications, strategies for adults with plantar fascia pain, whether to continue beta-blocker use after acute MI, and the outcomes of 5-alpha reductase inhibitor use prior to prostate cancer diagnosis. Links Migraine: https://www.bmj.com/content/386/bmj-2024-080107 Plantar fasciitis: https://pubmed.ncbi.nlm.nih.gov/38904119/  and https://pubmed.ncbi.nlm.nih.gov/16801514/ Beta-blockers post MI: https://pubmed.ncbi.nlm.nih.gov/39213187/ Prostate cancer: https://pubmed.ncbi.nlm.nih.gov/39190306/

Episode metadata supplied by the publisher feed · Published Dec 4, 2024

Embed this episode

NOW PLAYING

Episode 169: migraine, plantar fasciitis, beta-blocker duration and prostate cancer

0:00 28:37

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Primary Care Update?

This episode is 28 minutes long.

When was this Primary Care Update episode published?

This episode was published on December 4, 2024.

Can I download this Primary Care Update episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!